Bal Pharma Ltd. - BALPHARMA, 524824 corporate action history

Bal Pharma Ltd.

NSE: BALPHARMA | BSE: 524824 | ASM

Strong Performer, Under Radar

Download real time

105.70 1.70 (1.63%)

33.09% Fall from 52W High

60,595 NSE+BSE Volume

NSE 11 Apr, 2025 3:31 PM (IST)

168.3

Market Cap

Below industry Median

0.8

Beta 1Year

Low volatility

Bal Pharma Ltd. Bonus history

Bal Pharma Ltd. has not announced any bonus since Jan 1, 2000.

See all forthcoming Bonus and Splits

Bal Pharma Ltd. Split history

Bal Pharma Ltd. has not split the face value of the share since Jan 1, 2000.

See all forthcoming Bonus and Splits

Dividend history for Bal Pharma Ltd.

Bal Pharma Ltd. has declared 17 dividends since Sept. 1, 2004.

In the past 12 months, Bal Pharma Ltd. has declared an equity dividend amounting to ₹1.20 per share.

At the current share price of ₹105.7000, Bal Pharma Ltd.'s dividend yield is 1.14%.

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
18 Sep 2024	1.20	FINAL	-	Equity Share
18 Sep 2023	1.00	FINAL	-	Equity Share
13 Sep 2022	1.00	FINAL	-	Equity Share
16 Sep 2021	1.00	FINAL	-	Equity Share
17 Sep 2019	1.00	FINAL	-	Equity Share
14 Sep 2018	1.00	FINAL	-	Equity Share
14 Sep 2017	1.00	FINAL	-	Equity Share
15 Sep 2016	1.00	FINAL	-	Equity Share
15 Sep 2015	1.00	FINAL	-	Equity Share
12 Sep 2014	1.00	FINAL	-	Equity Share
12 Sep 2013	0.75	FINAL	-	Equity Share
17 Sep 2009	0.75	FINAL	-	Equity Share
09 Sep 2008	1.00	FINAL	-	Equity Share
07 Sep 2007	0.75	FINAL	-	Equity Share
07 Sep 2006	0.75	FINAL	-	Equity Share
09 Sep 2005	0.75	FINAL	-	Equity Share
01 Sep 2004	1.50	FINAL	-	Equity Share

VIEW MORE

See all forthcoming dividends Check out stocks with top dividend.

Board Meetings - Bal Pharma Ltd.

The latest board meeting for Bal Pharma Ltd. took place on 13 Feb 2025, for the purpose of Quarterly Results & Fund Raising

Ex-Date	Purpose	Notes
13 Feb 2025	Quarterly Results & Fund Raising	-
14 Nov 2024	Quarterly Results	-
12 Aug 2024	Quarterly Results, ESOP & A.G.M.	-
28 May 2024	Audited Results & Final Dividend	-
12 Feb 2024	Quarterly Results	-
08 Nov 2023	Quarterly Results & ESOP	-
11 Aug 2023	Quarterly Results & A.G.M.	-
29 May 2023	Audited Results & Final Dividend	-
06 Feb 2023	Quarterly Results	-
14 Nov 2022	Quarterly Results & ESOP	Inter alia, To convene Extra Ordinary General Meeting ( EGM ) for merger of Golden Drugs Pvt Ltd. a wholly owned subsidiary of the Company.

See all Board Meetings for Bal Pharma Ltd.

Rights history for Bal Pharma Ltd.

Bal Pharma Ltd. issued rights 1 time since April 7, 2005. Bal Pharma Ltd. had last issued Rights shares of ₹10/- in the ratio of 3:5 @ premium of ₹20/- on April 7, 2005.

Ex-Date	Ratio	Face Value	Premium	Record Date
07 Apr 2005	3:5	10	20	15 Apr 2005

See all Rights History for Bal Pharma Ltd.

Is Bal Pharma Ltd. worth buying?

52 Votes:

Buy 76.92%

Sell 13.46%

Hold 9.62%